Why the study?
Acute myocarditis has been linked primarily to SARS-CoV-2 mRNA vaccines, but cardiac side effects of other COVID-19 vaccine platforms remain unknown.
Does the Sinopharm BBIBP-CorV attenuated vaccine cause acute myocarditis in an 18-year-old female?
Does the Sinopharm BBIBP-CorV attenuated vaccine cause acute myocarditis in an 18-year-old female?
This case report suggests a possible link between the attenuated Sinopharm BBIBP-CorV vaccine and acute myocarditis, a complication previously associated primarily with mRNA vaccines.
Answers are grounded in this paper and cite their sources.
Should not change vaccination practice; leaves open possible myocarditis risk with inactivated COVID-19 vaccines.
Since the introduction of the SARS-CoV-2 vaccine, several side effects have been reported, including acute myocarditis, which is primarily associated with mRNA vaccines. However, the cardiac side effects of other forms of vaccination against COVID-19 are still unknown. Here, we present a case of a possible connection between myocarditis and attenuated vaccine Sinopharm BBIBP-CorV. An 18-year-old female patient was admitted to the intensive care unit (ICU) for the management of respiratory distress associated with hemodynamic instability one week after receiving an attenuated vaccine Myocarditis has been reported as a complication of SARS-CoV-2 mRNA vaccines. Our case report suggests a possible link between myocarditis and attenuated vaccines. Therefore, more research is warranted to determine this causal link.
No takes yet. Share an insight, caveat, or question.
Elkhadi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: